XPhyto Therapeutics (CSE: XPHY- OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to bring news the company has received European approval for their point-of-care 25-minute COVID-19 PCR Test system.
Rogers telling Proactive they are currently in discussions with various potential distribution and wholesale partners as well as potential licensees. XPhyto is targeting a sales launch in Europe in April 2021.